Expression, purification and functional characterization of human equilibrative nucleoside transporter subtype-1 (hENT1) protein from Sf9 insect cells
- 1 October 2015
- journal article
- Published by Elsevier in Protein Expression and Purification
- Vol. 114, 99-107
Abstract
No abstract availableKeywords
Funding Information
- Research Council of Finland (#132138)
- Sigrid Juselius Foundation and FP7 Marie Curie European Reintegration (#249081)
This publication has 29 references indexed in Scilit:
- The role of transporters in the toxicity of nucleoside and nucleotide analogsExpert Opinion on Drug Metabolism & Toxicology, 2012
- Physiological and Pharmacological Roles of Vascular Nucleoside TransportersJournal of Cardiovascular Pharmacology, 2012
- Analysis and update of the human solute carrier (SLC) gene superfamilyHuman Genomics, 2009
- Nucleoside transporters: from scavengers to novel therapeutic targetsTrends in Pharmacological Sciences, 2006
- Analysis of human equilibrative nucleoside transporter 1 (hENT1) protein in non-Hodgkin's lymphoma by immunohistochemistryLaboratory Investigation, 2005
- The equilibrative nucleoside transporter family, SLC29Pflügers Archiv - European Journal of Physiology, 2004
- (Section A: Molecular, Structural, and Cellular Biology of Drug Transporters) Mammalian Nucleoside TransportersCurrent Drug Metabolism, 2004
- The Process of Structure-Based Drug DesignChemistry & Biology, 2003
- Gemcitabine Transport in Xenopus Oocytes Expressing Recombinant Plasma Membrane Mammalian Nucleoside TransportersJNCI: Journal of the National Cancer Institute, 1999
- Molecular cloning and characterization of a nitrobenzylthioinosine-insensitive (ei) equilibrative nucleoside transporter from human placentaBiochemical Journal, 1997